.Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BA01_Beclometasone.Beclometasone .Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BA01_Beclometasone.Beclometasone| name: | Beclometasone |
| ATC code: | R03BA01 | route: | inhalation |
| n-compartments | 2 |
Beclometasone is a synthetic corticosteroid with potent anti-inflammatory properties, commonly used as an inhaled treatment for asthma and allergic rhinitis. It acts by reducing airway inflammation and bronchial hyperresponsiveness. Beclometasone is approved and widely used in current clinical practice.
Pharmacokinetic data reported for healthy adult volunteers (both sexes) after inhalation administration.
Kuna, P, et al., & Ciurlia, G (2022). Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma. Pharmacology research & perspectives 10(4) e980–None. DOI:10.1002/prp2.980 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35733414
Luo, Z, et al., & Mariotti, F (2022). Pharmacokinetic profile of beclometasone dipropionate/formoterol fumarate administered through a novel dry-powder inhaler in Chinese healthy volunteers. Pulmonary pharmacology & therapeutics 73-74 102129–None. DOI:10.1016/j.pupt.2022.102129 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35525480
Chawes, BL, et al., & Bisgaard, H (2014). Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent. Respiratory medicine 108(8) 1108–1116. DOI:10.1016/j.rmed.2014.05.007 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24993817